Skip to main content
. 2020 May 22;15(5):e0233212. doi: 10.1371/journal.pone.0233212

Fig 2. Overall survival of HCC patients with and without DAA therapy.

Fig 2

Patients with DAA therapy (A), BCLC stage 0-A (B), and BCLC stage B-C (C) had significantly higher overall survival rates than their counterparts.